Skip to main content

Peer Review reports

From: Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial

Original Submission
31 Mar 2016 Submitted Original manuscript
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
13 Aug 2016 Editorially accepted
20 Sep 2016 Article published 10.1186/s13063-016-1581-0

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215